These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 28599307

  • 1. Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis.
    Li B, Jin X, Meng H, Hu B, Zhang T, Yu J, Chen S, Guo X, Wang W, Jiang W, Wang J.
    Oncotarget; 2017 Jul 18; 8(29):47849-47860. PubMed ID: 28599307
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X, Luo X, Wu Y, Xia D, Chen W, Fang Z, Deng J, Hao Y, Yang X, Zhang T, Zhou L, Wu Y, Wang Q, Xu J, Hu X, Li L.
    Cell Physiol Biochem; 2018 Jul 18; 50(1):261-276. PubMed ID: 30282072
    [Abstract] [Full Text] [Related]

  • 3. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT, Yang YJ, Zhang ZD, An Q, Li N, Liu W, Yang B.
    J Ovarian Res; 2017 Jan 11; 10(1):1. PubMed ID: 28086946
    [Abstract] [Full Text] [Related]

  • 4. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y, Xu K, Yagüe E.
    Breast Cancer Res Treat; 2015 Jun 11; 151(2):269-80. PubMed ID: 25900794
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X, Han X, Wei P, Yang J, Sun J.
    Cancer Biol Ther; 2020 May 03; 21(5):452-462. PubMed ID: 32089062
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S, Jiao JW, Sun KX, Zong ZH, Zhao Y.
    Drug Des Devel Ther; 2015 May 03; 9():5225-35. PubMed ID: 26396496
    [Abstract] [Full Text] [Related]

  • 7. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
    Ye J, Zhang Z, Sun L, Fang Y, Xu X, Zhou G.
    Mol Biosyst; 2016 Oct 18; 12(11):3417-3424. PubMed ID: 27714074
    [Abstract] [Full Text] [Related]

  • 8. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, You M, Wang L.
    Mol Cancer; 2016 Nov 10; 15(1):70. PubMed ID: 27832783
    [Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA Linc00518 promotes paclitaxel resistance of the human prostate cancer by sequestering miR-216b-5p.
    He J, Sun M, Geng H, Tian S.
    Biol Cell; 2019 Feb 10; 111(2):39-50. PubMed ID: 30462844
    [Abstract] [Full Text] [Related]

  • 10. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M, Chen W, Zhang H, Zhang Y, Ke F, Wu X, Zhang Y, Weng M, Liu Y, Gong W.
    Oncotarget; 2016 Dec 13; 7(50):83060-83070. PubMed ID: 27825112
    [Abstract] [Full Text] [Related]

  • 11. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C, Chen QB, Han ZD, Zhang YQ, He HC, Chen JH, Chen YR, Yang SB, Wu YD, Zeng YR, Qin GQ, Liang YX, Dai QS, Jiang FN, Wu SL, Zeng GH, Zhong WD, Wu CL.
    Clin Cancer Res; 2015 Nov 01; 21(21):4922-34. PubMed ID: 26080838
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
    Eoh KJ, Lee SH, Kim HJ, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.
    Biochem Biophys Res Commun; 2018 Mar 04; 497(2):513-520. PubMed ID: 29452092
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.
    Ao X, Nie P, Wu B, Xu W, Zhang T, Wang S, Chang H, Zou Z.
    Cell Death Dis; 2016 Nov 10; 7(11):e2463. PubMed ID: 27831559
    [Abstract] [Full Text] [Related]

  • 14. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y, Qiu Y, Yagüe E, Ji W, Liu J, Zhang J.
    Cell Death Dis; 2016 Jun 30; 7(6):e2291. PubMed ID: 27362808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD, Li XS, Meng XN, Yan J, Zong ZH.
    Tumour Biol; 2016 Aug 30; 37(8):10499-506. PubMed ID: 26850595
    [Abstract] [Full Text] [Related]

  • 17. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.
    Singh S, Chitkara D, Mehrazin R, Behrman SW, Wake RW, Mahato RI.
    PLoS One; 2012 Aug 30; 7(6):e40021. PubMed ID: 22768203
    [Abstract] [Full Text] [Related]

  • 18. Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.
    Wen D, Peng Y, Lin F, Singh RK, Mahato RI.
    Cancer Res; 2017 Jun 15; 77(12):3244-3254. PubMed ID: 28428276
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
    Ma X, Zou L, Li X, Chen Z, Lin Q, Wu X.
    Biomed Pharmacother; 2018 Mar 15; 99():445-450. PubMed ID: 29665645
    [Abstract] [Full Text] [Related]

  • 20. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Yang Y, Lu Y, Wang L, Mizokami A, Keller ET, Zhang J, Fu J.
    Oncol Rep; 2016 Jul 15; 36(1):559-66. PubMed ID: 27175797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.